-
Swedish authorities inspect worksite conditions at steel startup Stegra
-
Keys withdraws from WTA Finals with illness
-
Prince Harry says proud to be British despite new life in US
-
EU strikes last-ditch deal on climate targets as COP30 looms
-
Stocks retreat as tech bubble fears grow
-
Shein opens first permanent store amid heavy police presence
-
West Indies edge New Zealand despite Santner brilliance
-
French pair released by Iran await return home
-
German factory orders up but outlook still muted
-
Death toll tops 100 as Philippines digs out after typhoon
-
Attack on key city in Sudan's Kordofan region kills 40: UN
-
'No one could stop it': Sudanese describe mass rapes while fleeing El-Fasher
-
Champagne and cheers across New York as Mamdani soars to victory
-
Medieval tower collapse adds to Italy's workplace toll
-
BMW boosts profitability despite China, tariff woes
-
South Africa's Wiese wary of 'hurt' France before re-match
-
Beyond limits: Croatian freediver's breathtaking record
-
Tottenham supporting Udogie after alleged gun threat in London
-
Thunder roll Clippers to stay unbeaten as SGA keeps streak alive
-
In appeal, Australian mushroom murderer alleges 'miscarriage of justice'
-
Toyota hikes profit forecasts 'despite US tariffs'
-
Ex-France lock Willemse challenges Meafou to become 'the bully'
-
Ukrainians to honour sporting dead by building country they 'died for': minister
-
At least 7 dead after UPS cargo plane crashes near Louisville airport
-
US Supreme Court hears challenge to Trump tariff powers
-
US government shutdown becomes longest in history
-
India's Modi readies bellwether poll in poorest state
-
Green goals versus growth needs: India's climate scorecard
-
Where things stand on China-US trade after Trump and Xi talk
-
Sri Lanka targets big fish in anti-corruption push
-
NY elects leftist mayor on big election night for Democrats
-
Injured Jordie Barrett to miss rest of All Blacks tour
-
Asian markets tumble as tech bubble fears grow
-
Pay to protect: Brazil pitches new forest fund at COP30
-
Iraq's social media mercenaries dying for Russia
-
Young leftist Trump foe elected New York mayor
-
Concerns at ILO over expected appointment of close Trump advisor
-
Venus Williams to return to Auckland Classic at the age of 45
-
No deal yet on EU climate targets as COP30 looms
-
Typhoon death toll climbs to 66 in the Philippines
-
NATO tests war preparedness on eastern flank facing Russia
-
Uncapped opener Weatherald in Australia squad for first Ashes Test
-
Liverpool down Real Madrid in Champions League, Bayern edge PSG
-
Van Dijk tells Liverpool to keep calm and follow Arsenal's lead
-
PSG left to sweat on injuries to Dembele and Hakimi
-
Reddit, Kick to be included in Australia's social media ban
-
Ex-Zimbabwe cricket captain Williams treated for 'drug addiction'
-
Padres ace Darvish to miss 2026 MLB season after surgery
-
Diaz hero and villain as Bayern beat PSG in Champions League showdown
-
Liverpool master Real Madrid on Alexander-Arnold's return
Abortion pill at the center of a US court battle
A widely used abortion pill is at the center of the latest legal battle in America's ongoing debate over abortion.
The US Supreme Court on Wednesday said that it would weigh in on restrictions imposed by a lower court on the drug mifepristone.
Here is the background on the drug and its use:
- How widespread is abortion pill use? -
According to the Guttmacher Institute, the pill accounted for more than half -- 53 percent -- of the 930,160 abortions documented by the reproductive health research and policy organization in the United States in 2020.
While the number of so-called medication abortions has gone up dramatically in the United States in recent years, it is still not as prevalent as in several European nations.
In France, for example, medication abortions represented 70 percent of the total number of abortions in 2020.
- How does it work? -
The abortion pill is different from the "morning after" pill, which is taken by a woman after sexual intercourse to prevent becoming pregnant.
The abortion pill is taken to induce an abortion once a woman confirms that she is pregnant.
The process in fact involves more than one pill. The first, mifepristone, also known as RU 486, stops a pregnancy from proceeding normally by blocking production of the hormone progesterone.
Another drug, misoprostol, is taken up to 48 hours later and causes cramps, bleeding and the emptying of the uterus.
Abortion pills can be used at home and a medical setting is not required.
- When was the abortion pill approved? -
The US Food and Drug Administration (FDA) gave the green light to mifepristone and misoprostol in 2000 for use up to seven weeks of pregnancy.
It was later approved for use up to 10 weeks of pregnancy, after which a woman would need to undergo an abortion through other means, such as vacuum aspiration.
The average cost of a medication abortion at Planned Parenthood is $580 but it can cost up to $800.
- Is it safe and effective? -
Use of the abortion pill during the specified time period is considered to be safe and effective by medical experts.
Pregnancies are successfully terminated in more than 95 percent of cases where the pill is used, according to studies.
Serious complications -- excessive bleeding, fever, infection or allergic reaction -- which require a medical consult, are rare.
The abortion pill does not work for ectopic pregnancies, which account for around two percent of all pregnancies and occur when a fertilized egg grows outside the uterus.
- Where is the pill available? -
Around 20 US states have banned or severely restricted access to abortions, including medication abortions, since the Supreme Court's ruling in June 2022 overturning the constitutional right to the procedure.
But anti-abortion groups are seeking to restrict access to mifepristone nationwide, including in states where abortion has remained legal.
The case before the Supreme Court concerns limiting the use of mifepristone to the first seven weeks of pregnancy, instead of 10, and blocking it from being distributed by mail.
L.Maurer--VB